ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $27,000 | -49.1% | 522 | -46.3% | 0.00% | – |
| Q3 2019 | $53,000 | +112.0% | 972 | +56.8% | 0.00% | – |
| Q2 2019 | $25,000 | +47.1% | 620 | +6.5% | 0.00% | – |
| Q1 2019 | $17,000 | -5.6% | 582 | +9.2% | 0.00% | – |
| Q4 2018 | $18,000 | -37.9% | 533 | -22.9% | 0.00% | – |
| Q3 2018 | $29,000 | +38.1% | 691 | +5.8% | 0.00% | – |
| Q2 2018 | $21,000 | -40.0% | 653 | -6.4% | 0.00% | – |
| Q1 2018 | $35,000 | -32.7% | 698 | -28.4% | 0.00% | -100.0% |
| Q4 2017 | $52,000 | -45.3% | 975 | -40.3% | 0.00% | 0.0% |
| Q3 2017 | $95,000 | +28.4% | 1,634 | +9.2% | 0.00% | 0.0% |
| Q2 2017 | $74,000 | +13.8% | 1,497 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $65,000 | +306.2% | 1,502 | +352.4% | 0.00% | – |
| Q4 2016 | $16,000 | -15.8% | 332 | -15.5% | 0.00% | – |
| Q3 2016 | $19,000 | -20.8% | 393 | -16.2% | 0.00% | -100.0% |
| Q2 2016 | $24,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |